This adds new evidence that BECN1 have oncosupportive roles and provides a new therapeutic strategy that inhibiting the function of BECN1 may be an effective way for the treatment of NSCLC under certain circumstance. Here, BECN1 is linked to non-small cell lung carcinoma.